The Nishinihon Journal of Dermatology
Online ISSN : 1880-4047
Print ISSN : 0386-9784
ISSN-L : 0386-9784
Search
Advanced search
OR
Browse
Search
Volume 84, Issue 3
Displaying 1-17 of 17 articles from this issue
Show all abstracts
    • |<
    • <
    • 1
    • >
    • >|
Index
Color Atlas
Mini Review
Clinical Case Reports
Statistics
Dermatological Researchers in the World
  • Dr. Michael Rosenblum
    Michael Rosenblum
    Article type: letter
    2022 Volume 84 Issue 3 Pages 245-246
    Published: June 01, 2022
    Released on J-STAGE: July 25, 2022
    DOIhttps://doi.org/10.2336/nishinihonhifu.84.245
    JOURNAL RESTRICTED ACCESS
    Show abstractHide abstract

    Dr. Rosenblum received his medical degree and PhD from the Medical College of Wisconsin. Subsequently, he completed his dermatology residency training at UCSF in the prestigious Physician-Scientist Training Pathway.He joined the UCSF faculty in 2012 and since that time has become one of the world's leading skin immunologists.Dr. Rosenblum is a recipient of the Burroughs Wellcome Fund Career Award for Medical Scientists,the NIH Director's New Innovator Award, the Dermatology Foundation's Charles & Daneen Stiefel Scholar Award in Autoimmune & Connective Tissue Diseases, as well as multiple NIH R01 & R21 awards.Dr. Rosenblum was named the William Montagna Lecturer by the Society for Investigative Dermatology. He was the scientific co-founder of Delinia Bio., which was sold to Celgene in 2017. Currently, Dr. Rosenblum is co-founder of TRex Bio. and Sitryx Bio.

    View full abstract
    Download PDF (1292K)
    • |<
    • <
    • 1
    • >
    • >|
feedback
 Top